ASPIRIN Cardio 100 mg pills, 98 pcs.
Important!
Unreasonable use of medicines is harmful to health! Carefully read the instructions for use or relevant information on the package! Talk to your doctor or pharmacist about using the medicine.

ASPIRIN Cardio 100 mg pills, 98 pcs.

BAYER/SCHERING
Total
9.53 €
Expiration date: 2028-01-30
Active substances: Acetylsalicylic acid; 1 tablet contains 100 mg of acetylsalicylic acid.
Read more
Important information
The appearance of the product may differ from the one shown in the photo
Product prices can vary in pharmacies

Aspirin Cardio tablets are intended for the following cardiovascular use: Reducing the risk of mortality in patients with suspected acute myocardial infarction. Reducing the risk of morbidity and mortality in patients with previous myocardial infarction. Secondary prevention of stroke. Reducing the risk of temporary ischemic attacks and stroke in patients with transient ischemia. Reducing the risk of morbidity and mortality in patients with stable and unstable angina. Prevention of thromboembolism after blood vessel surgery or surgery such as PTCA, CABG, carotid endarterectomy, arteriovenous shunting. Reducing the risk of deep vein thrombosis and pulmonary embolism after prolonged immobility, such as after major surgeries. Reducing the risk of first myocardial infarction in people with cardiovascular risk factors, for example, diabetes mellitus, hyperlipidemia, hypertension, obesity, in smokers, in the elderly.

More about this product
product
10118392 ASPIRIN Cardio 100 mg tabletes, 98 gab. https://images.e-menessaptieka.lv/unsafe/fit-in/588x588/a6/56/9ecbba05ce6a10e73f680747763f.png InStock 9.53 EUR 9.53 <p style="text-align:justify;">Aspirin Cardio tabletes ir paredzētas sekojošai kardiovaskulārai lietošanai: saslimstības un mirstības riska samazināšanai pacientiem ar agrāk pārciestu miokarda infarktu, sekundārai insulta profilaksei, pārejošu išēmisku lēkmju un insulta riska samazināšanai pacientiem ar pārejošu išēmiju, saslimstības un nāves gadījumu riska samazināšanai pacientiem ar stabilu un nestabilu stenokardiju, trombembolijas novēršanai pēc asinsvadu ķirurģijas vai ķirurģiskas iejaukšanās, dziļo vēnu trombozes un plaušu embolijas riska samazināšanai pēc ilgtermiņa imobilizācijas, pirmā miokarda infarkta riska samazināšanai cilvēkiem ar kardiovaskulāra riska faktoriem.</p> Menessaptieka/Visas preces/Veselībai/Sirds un asinsvadi